Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Harp melodies may tame Dementia's sundowning storm

NCT ID NCT07748013

Symptom relief Sponsor: LNA SANTE Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This study tests whether weekly live harp music sessions can reduce behavioral symptoms like agitation and anxiety in nursing home residents with moderate-to-severe dementia. Participants in memory care units will listen to a harp therapist play during the late afternoon, a time when such symptoms often worsen. Researchers will track changes in behavior, medication use, and well-being over 12 weeks, with follow-up assessments after the sessions end.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Harp therapy (receptive music therapy)
What this could lead to
If harp therapy proves effective, it could offer a drug-free way to reduce agitation and anxiety in people with dementia, potentially improving quality of life and reducing reliance on medications.
What could go wrong
This is a small, single-center study without a control group, so results may not apply broadly. The benefits of music therapy can vary widely between individuals, and the study does not yet prove long-term effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

25 people

The number who actually took part.

Started

Oct 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All eligible residents from the two memory care units of Villa Éléonore, a nursing home operated by LNA Santé in France.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Living permanently in a memory care unit (unité protégée) of Villa Éléonore nursing home for at least 2 months * Diagnosed with a moderate-to-severe neurodegenerative disease (such as Alzheimer's disease or a related condition), AND/OR Mini-Mental State Examination (MMSE) score of 15 or below (or MMSE not evaluable), assessed within the last 12 months * Presenting moderate-to-severe disruptive behavioral difficulties, such as anxiety, agitation, nighttime wandering, or difficulty falling asleep * Participant and/or their legal representative has been informed about the study and has not objected to the use of their pseudonymized data Exclusion Criteria: * Unstabilized psychiatric condition * Uncorrected hearing impairment causing sensory isolation (i.e., without appropriate hearing aids) * Documented end-of-life status in the medical record

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Agitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder Behavior Behavioral Symptoms dementia neurodegenerative disease Psychomotor Agitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Agitation Behavioral symptoms Dementia Neurodegenerative diseases

Contacts and locations

Locations

  • Villa Eléonore

    Montlouis-sur-Loire, 37270, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.